Skip to Content

Alphagan P Dosage

Generic name: brimonidine tartrate 1mg in 1mL
Dosage form: ophthalmic solution

Medically reviewed on October 23, 2017.

The recommended dose is one drop of ALPHAGAN® P in the affected eye(s) three times daily, approximately 8 hours apart. ALPHAGAN® P ophthalmic solution may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure. If more than one topical ophthalmic product is to be used, the different products should be instilled at least 5 minutes apart.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Next → Professional

More about Alphagan P (brimonidine ophthalmic)

Consumer resources

Other brands: Alphagan, Lumify

Professional resources

Related treatment guides

Drug Status

Rx

Availability Prescription only

Pregnancy & Lactation Risk data available

CSA Schedule* Not a controlled drug

Approval History Drug history at FDA

Manufacturer

Allergan plc

Drug Class

Ophthalmic glaucoma agents

Related Drugs

Glaucoma, Open Angle timolol ophthalmic, epinephrine ophthalmic, Lumigan, latanoprost ophthalmic, brimonidine ophthalmic, Xalatan, Travatan, pilocarpine ophthalmic, Cosopt, Azopt, Alphagan, dorzolamide ophthalmic, More...

Intraocular Hypertension timolol ophthalmic, Lumigan, latanoprost ophthalmic, brimonidine ophthalmic, Xalatan, Travatan, pilocarpine ophthalmic, Combigan, Cosopt, Azopt, Alphagan, dorzolamide ophthalmic, More...

Alphagan P Rating

4 User Reviews 4.3/10

Get Email Updates

Subscribe to free Drugs.com newsletters.

By clicking Subscribe, I agree to the Drugs.com Terms & Conditions and Privacy Policy and understand that I may opt out of Drugs.com subscriptions at any time.

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex® (updated Oct 1st, 2018), Cerner Multum™ (updated Oct 2nd, 2018), Wolters Kluwer™ (updated Oct 2nd, 2018) and others. To view content sources and attributions, please refer to our editorial policy.